Page last updated: 2024-11-04

vorinostat and Angiomatosis Retinae

vorinostat has been researched along with Angiomatosis Retinae in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Research Excerpts

ExcerptRelevanceReference
"Vorinostat was tolerated without serious adverse events by all patients."1.91Proteostasis Modulation in Germline Missense von Hippel Lindau Disease. ( Alvarez, R; Asuzu, DT; Bugarini, A; Chew, EY; Chittiboina, P; Elkahloun, A; Linehan, M; Lonser, RR; Mandal, D; Maric, D; Mastorakos, P; Mullaney, D; Scott, G; Stoica, S; Yang, C; Zhuang, Z, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chittiboina, P1
Mandal, D1
Bugarini, A1
Asuzu, DT1
Mullaney, D1
Mastorakos, P1
Stoica, S1
Alvarez, R1
Scott, G1
Maric, D1
Elkahloun, A1
Zhuang, Z1
Chew, EY1
Yang, C1
Linehan, M1
Lonser, RR1

Other Studies

1 other study available for vorinostat and Angiomatosis Retinae

ArticleYear
Proteostasis Modulation in Germline Missense von Hippel Lindau Disease.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2023, 06-13, Volume: 29, Issue:12

    Topics: Biological Products; Central Nervous System Neoplasms; Hemangioblastoma; Humans; Proteostasis; von H

2023